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▼Preparative separation of cell populations on the basis
of characteristics of cell surface markers represents an im-
portant technique for numerous research applications in
biology and medicine. Increasingly, this approach is be-
ing adopted for the purification of mammalian cells trans-
duced with DNA, as a preferred alternative to drug selec-
tion in studies on ectopic modulation of gene function.
By using antibodies to surface markers encoded by co-
transfected genes [e.g. CD2 (Ref. 1) or immunogloblins],
several methods such as fluorescence activated cell sort-
ing (FACS) immuno-magnetic bead separation and simple
‘panning’ have been used to facilitate the purification of
the target, transduced cell population from what is often a
vast excess of non-transduced cells Of these methods, pan-
ning is by far the simplest and least expensive (Ref. 2) but is
generally considered to be too crude for most applications.
We report here on some simplemodifications to positive se-
lection of antigen-marked cell populations by panning that
dramatically enhances the performance of this procedure.
Petri dishes (e.g. 3.5 cm diameter Sterilin, bacteriological
grade) are pre-coated overnight at 4◦C with the appropriate
antibody [10 µg/ml in phosphate buffered saline (PBS)],
washed several times with PBS and treated with bovine
serum albumin blocking solution (0.2% in PBS) for 1 h at
room temperature before application of the cell suspen-
sion (approximately 2 X 106 cells in 4 ml of standard cell
growth medium per dish). Instead of relying on gravity to
sediment the cells as in conventional panning, the Petri
dishes are centrifuged for 10 min at 500 rev/min in a bench
centrifuge swing-out rotor (e.g. MSE Mistral 2000) at room
temperature, supported on the top of plastic, multi-well
tube adaptors. By compacting the cells onto the antibody-
coated surface in this way, the antigen-mediated bonding
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of the positive cell population is enhanced, whilst antigen-
negative cells are still readily detachable from the surface,
provided higher centrifugation speeds are avoided. In con-
ventional panning, this latter cell population is removed
through several ‘washing’ stages (Ref. 2), a rather ineffi-
cient procedure which can also result in significant and un-
acceptable loss of the target cell population. To overcome
this problem, we have developed a procedure for quanti-
tative removal of unbound cells by gravity sedimentation
which can be performed under aseptic conditions in a lam-
inar flow cabinet. Following the centrifugation step above,
the level of liquid in the Petri dish is increased by very
gently pipetting on fresh medium until the surface menis-
cus is raised just above the top of the dish. A Petri dish
lid of somewhat larger dimension (e.g. 6 cm) is then gen-
tly laid on the top, eliminating any air bubbles (a small
overflow of medium at this stage is inconsequential). The
whole assemblage, which is now robustly held together by
suction, is swiftly inverted and unbound cells allowed to
sediment for around 15min at room temperature. The Petri
dish, still in the inverted orientation, is then briskly ‘peeled
off’, allowing the medium containing unbound cells to col-
lect in the lid below whilst retaining the antibody-bound
cells in the dish to be recovered by re-suspending in fresh
medium.
In the working example illustrated (Fig. 1), human Daudi
B lymphoblastoid cells were co-electroporated with DNA
constructs encoding a truncated rat CD2 surface antigen to
facilitate purification (Ref. 1), a luciferase reporter to quan-
titate recovery (Ref. 3) and a β-galactosidase (lacZ) marker
to monitor purification (Ref. 4). From a starting population
comprising 5−10% lacZ-positive cells (Fig. 1a), 65% of the
luciferase activity was recovered as a CD2-positive popula-
tion containing approximately 80% lacZ-positive cells (Fig.
1b).
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FIGURE 1. Purification of lacZ-transfected cells using a CD2 surface marker. Approximately 107 Daudi B lymphoblastoid cells in 350 µl of RPMI-10%
fetal calf serum were co-electrophoresed with 2.5 µg of each of the following DNA constructs; pRCD2- 2 (Ref. 1) encoding a truncated rat CD2 antigen,
each of the plasmids pUHGI5-1 (Ref. 3) and pUHC13-3 (Ref. 3) encoding the tetracycline-responsive transactivator (tTA) and a tTA-responsive luciferase
reporter, respectively, and CMV β-gal (Ref. 4) encoding the Escherichia coli β-galactosidase gene, using a Biorad electroporator (set at 950 µF, 280 V).
After 24 h, 2 X 106 cells were subjected to purification using immobilized anti-rat CD2 antibody (Serotec) as described in the text. The photographs
show X-gal-staining (Ref. 4) of β-galactosidase-positive cells (a) in the unfractionated population and (b) following purification of CD2-positive cells.
Although we developed this procedure for the specific
application of purifying transiently transfected cells, the
method would be equally applicable to any circumstance
requiring preparative purification of specific cell popula-
tions (including stable transfectants) on the basis of surface
antigen characteristics. Because the operation is completed
within 30 min, excellent cell viability is preserved, no spe-
cialized expensive equipment is required and the method
can be adapted for use on any scale.
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